التصنيف: attention-deficit hyperactivity disorder المادة الفعالة:atomoxetine
description: atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (adhd). dose: dosing of children and adolescents up to 70 kg body weight initial: the recommended dose is 0.5 mg/kg and increas
